Skip to main content
Premium Trial:

Request an Annual Quote

Acolyte and Berthold Technologies Sign Marketing Alliance for Rapitect Assays

NEW YORK, June 1 (GenomeWeb News) - Berthold Technologies GmbH & Co. KG will distribute Acolyte's BacLite RapiTect range of enumeration assays in Europe and U.S. under a marketing agreement, Acolyte Biomedica said today.


The assay range uses adenylate kinase as a highly sensitive marker of viable cells. The technology, originally developed by the UK Ministry of Defence, is up to 100 times more sensitive than standard ATP bioluminescence and up to one million times more sensitive than optical measurements. Acolyte has exclusive licenses to the technology for commercial exploitation in life sciences research.


Financial details were not disclosed.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.